Ursolic Acid Ameliorates the Injury of H9c2 Cells Caused by Hypoxia and Reoxygenation Through Mediating CXCL2/NF-κB Pathway

被引:4
|
作者
Bian, Zhongrui [1 ]
Xu, Fei [1 ]
Liu, Hui [1 ]
Du, Yimeng [1 ]
机构
[1] Shandong Univ, Dept Cardiol, Hosp 2, 247 Beiyuan St, Jinan 250033, Shandong, Peoples R China
关键词
HY-18739; Inflammation; Oxidative stress; siRNA; NF-KAPPA-B; ISCHEMIA-REPERFUSION; OXIDATIVE STRESS; PROTECTS; INFLAMMATION; ACTIVATION; EXPRESSION; CHEMOKINES; CXCL2;
D O I
10.1536/ihj.21-807
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ursolic acid (UA) has been reported to possess several biological benefits, such as anti-cancer, anti-inflammation, antibacterial, and neuroprotective functions. This study detects the function and molecular mecha-nism of UA in H9c2 cells under hypoxia and reoxygenation (H/R) conditions. Under H/R stimulation, the effects of UA on H9c2 cells were examined using ELISA and western blot assays. The Comparative Toxicogenomics Database was employed to analyze the target molecule of UA. Small interfering RNA was used to knock down CXCL2 expression, further exploring the function of CXCL2 in H/R-induced H9c2 cells. The genes related to the nuclear factor-kappa B (NF--KB) pathway were assessed using western blot analysis. Significant effects of UA on H/R-induced H9c2 cell damage were observed, accompanied by reduced inflammation and oxidative stress injury. Additionally, the increased level of CXCL2 in H/R-induced H9c2 cells was reduced after UA stimulation. Moreover, CXCL2 knockdown strengthened the beneficial effect of UA on H/R-induced H9c2 cells. HY-18739, an activator of the NF-kappa B pathway, can increase CXCL2 expression. Moreover, the increased levels of p-P65 NF-kappa B and p-I-KB alpha in H/R-induced H9c2 cells were remarkably attenuated by UA treatment. In summary, the results indicated that UA may alleviate the damage of H9c2 cells by targeting the CXCL2/NF-kappa B pathway under H/R conditions.
引用
收藏
页码:755 / 762
页数:8
相关论文
共 50 条
  • [1] Schizandrin B attenuates hypoxia/reoxygenation injury in H9c2 cells by activating the AMPK/Nrf2 signaling pathway
    Zhao, Bo
    Li, Guang-Ping
    Peng, Jian-Jun
    Ren, Li-Hui
    Lei, Li-Cheng
    Ye, Hui-Ming
    Wang, Zuo-Yan
    Zhao, Sheng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (03)
  • [2] Plantamajoside protects H9c2 cells against hypoxia/reoxygenation-induced injury through regulating the akt/Nrf2/HO-1 and NF-κB signaling pathways
    Zeng, Guangwei
    An, Huixian
    Fang, Dong
    Wang, Wei
    Han, Yang
    Lian, Cheng
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2022, 42 (02) : 125 - 132
  • [3] Sanguinarine attenuates hypoxia/reoxygenation-triggered H9c2 cell injury through activation of the Nrf2/NLRP3 pathway
    Qiu, Bo
    Li, Xin
    Wang, Wenna
    JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2025,
  • [4] Eleutheroside E decreases oxidative stress and NF-κB activation and reprograms the metabolic response against hypoxia-reoxygenation injury in H9c2 cells
    Wang, Shanyue
    Yang, Xuming
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 84
  • [5] Lidocaine protects H9c2 cells from hypoxia-induced injury through regulation of the MAPK/ERK/NF-κB signaling pathway
    Jin, Haibin
    Yu, Jin
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (05) : 4125 - 4131
  • [6] Dexmedetomidine Attenuates Hypoxia/Reoxygenation Injury of H9C2 Myocardial Cells by Upregulating miR-146a Expression via the MAPK Signal Pathway
    Chu, Yi
    Teng, Jiwei
    Feng, Pin
    Liu, Hui
    Wang, Fangfang
    Wang, Haiyan
    PHARMACOLOGY, 2022, 107 (1-2) : 14 - 27
  • [7] Prokineticin 2 relieves hypoxia/reoxygenation-induced injury through activation of Akt/mTOR pathway in H9c2 cardiomyocytes
    Su, Gang
    Sun, Guangli
    Liu, Hai
    Shu, Liliang
    Zhang, Weiwei
    Liang, Zhenxing
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2020, 48 (01) : 345 - 352
  • [8] Triptolide reduces ischemia/reperfusion injury in rats and H9C2 cells via inhibition of NF-B, ROS and the ERK1/2 pathway
    Yang, Bin
    Yan, Ping
    Yang, Guang-Zhao
    Cao, Hui-Li
    Wang, Fei
    Li, Bao
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 41 (06) : 3127 - 3136
  • [9] TRIM38 protects H9c2 cells from hypoxia/reoxygenation injury via the TRAF6/TAK1/NF-κB signalling pathway
    Lu, Zhengri
    Deng, Mengen
    Ma, Genshan
    Chen, Lijuan
    PEERJ, 2022, 10
  • [10] Dexmedetomidine-mediated regulation of miR-17-3p in H9C2 cells after hypoxia/reoxygenation injury
    Yuan, Tianhui
    Yang, Zhongqi
    Xian, Shaoxiang
    Chen, Yang
    Wang, Lingjun
    Chen, Weitao
    Long, Wenjie
    Che, Yuanyuan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (02) : 917 - 925